During the past decade, Eukarya Pharmasite S.C. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Eukarya Pharmasite S.C." are "COVID-19" (4 trials), "Dermatitis" (1 trials), "Dermatitis, Atopic" (1 trials), "Eczema" (1 trials) and "Genetic Diseases, Inborn" (1 trials). Many other conditions were trialed in "Eukarya Pharmasite S.C." in a lesser frequency.

Most popular intervention types in "Eukarya Pharmasite S.C." are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "PF-07321332" (3 trials), "Ritonavir" (3 trials), "Placebo" (2 trials), "Dupilumab" (1 trials) and "Injectable Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eukarya Pharmasite S.C." are 5 trials for "All" genders.

Currently, there are NaN active trials in "Eukarya Pharmasite S.C.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Eukarya Pharmasite S.C., 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Eukarya Pharmasite S.C., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".